| Primary |
| Neutropenia |
34.7% |
| Hodgkin's Disease |
16.8% |
| Product Used For Unknown Indication |
12.9% |
| Hepatitis C |
6.9% |
| Chronic Hepatitis |
5.9% |
| Chemotherapy |
5.0% |
| Breast Cancer |
4.0% |
| Gastric Cancer |
3.0% |
| Drug Use For Unknown Indication |
2.0% |
| Prophylaxis |
2.0% |
| White Blood Cell Count Increased |
2.0% |
| Asthma |
1.0% |
| Bone Marrow Conditioning Regimen |
1.0% |
| Febrile Neutropenia |
1.0% |
| Leukopenia |
1.0% |
| Neoplasm Malignant |
1.0% |
|
| Hypersensitivity |
10.6% |
| Psoriasis |
10.6% |
| Interstitial Lung Disease |
8.5% |
| Neutrophil Count Decreased |
8.5% |
| Vomiting |
8.5% |
| Chest Pain |
6.4% |
| Red Cell Distribution Width Increased |
6.4% |
| Renal Disorder In Pregnancy |
6.4% |
| Haematocrit Decreased |
4.3% |
| Intestinal Ischaemia |
4.3% |
| Neutropenia |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Blood Lactate Dehydrogenase Increased |
2.1% |
| Dysphagia |
2.1% |
| Eosinophilia |
2.1% |
| Generalised Erythema |
2.1% |
| Granulocytopenia |
2.1% |
| Hyperhidrosis |
2.1% |
| Hypovolaemic Shock |
2.1% |
| Leukopenia |
2.1% |
|
| Secondary |
| Chronic Hepatitis |
16.9% |
| Drug Use For Unknown Indication |
14.1% |
| Product Used For Unknown Indication |
9.9% |
| Breast Cancer Female |
8.5% |
| Hepatitis C |
8.5% |
| White Blood Cell Count Increased |
8.5% |
| Multiple Myeloma |
7.0% |
| Thrombosis Prophylaxis |
5.6% |
| Colony Stimulating Factor Prophylaxis |
4.2% |
| Gastric Cancer |
4.2% |
| Neutropenia |
4.2% |
| Plasma Cell Myeloma |
4.2% |
| Asthma |
1.4% |
| Leukopenia |
1.4% |
| Prophylaxis |
1.4% |
|
| Red Cell Distribution Width Increased |
19.2% |
| Thrombosis |
15.4% |
| Renal Failure |
11.5% |
| Rhabdomyolysis |
11.5% |
| Granulocytopenia |
7.7% |
| Leukopenia |
7.7% |
| Bronchopneumonia |
3.8% |
| Gangrene |
3.8% |
| Neoplasm Malignant |
3.8% |
| Stomatitis |
3.8% |
| Urticaria |
3.8% |
| Vaginal Inflammation |
3.8% |
| White Blood Cell Disorder |
3.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.0% |
| Prophylaxis |
8.4% |
| Non-hodgkin's Lymphoma |
8.0% |
| Breast Cancer |
5.9% |
| Prophylaxis Against Graft Versus Host Disease |
5.7% |
| Hypertension |
5.1% |
| Neutropenia |
4.9% |
| Premedication |
4.9% |
| Product Used For Unknown Indication |
4.7% |
| Hepatitis C |
4.3% |
| Non-small Cell Lung Cancer |
4.1% |
| Hiv Infection |
3.9% |
| Anaemia |
2.9% |
| Bladder Cancer |
2.9% |
| Lung Neoplasm Malignant |
2.2% |
| Nausea |
2.2% |
| Antifungal Prophylaxis |
2.0% |
| Chronic Lymphocytic Leukaemia |
2.0% |
| Multiple Myeloma |
2.0% |
| Leukopenia |
1.8% |
|
| Vomiting |
17.2% |
| Pleural Effusion |
9.2% |
| Tooth Disorder |
6.9% |
| Febrile Neutropenia |
5.7% |
| Sepsis |
5.7% |
| Thrombocytopenia |
5.7% |
| Weight Increased |
5.7% |
| Infusion Site Erythema |
4.6% |
| Neutropenia |
4.6% |
| Visual Impairment |
4.6% |
| Cholecystitis Acute |
3.4% |
| Jaundice |
3.4% |
| Oesophageal Candidiasis |
3.4% |
| Pneumonitis |
3.4% |
| Pyrexia |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Application Site Papules |
2.3% |
| Gastrointestinal Perforation |
2.3% |
| Haemoptysis |
2.3% |
| Left Ventricular Dysfunction |
2.3% |
|
